Shares of Bio-Techne Corp. rallied 5.67% to $63.03 Monday, on what proved to be an all-around favorable trading session for ...

Bio-Techne (TECH) is back in focus after a recent analyst downgrade that cited softer organic growth and a weaker free cash ...

The leading life sciences reagents and instruments company is expected to announce its fiscal second-quarter earnings for ...

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables ...

Ousted Venezuelan President Nicolás Maduro pleaded not guilty to narcotrafficking charges during his arraignment in U.S. federal court Monday, defiantly telling a judge that he was still the head of ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...

"Thompson Street is pleased to support PestCo's continued expansion in the Houston metropolitan area through the acquisition of Bio-Tech, a well-established and respected player in the region," said ...

Cemtrex completed its acquisition of a Texas military engineering firm. Shares gained 35.5% to $3.94 in after-hours trading Thursday. Olin cut its fourth-quarter outlook, citing a slowdown in ...

Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that it ...

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...